'Landmark initiative': Ramaphosa, Macron announce new SA-based Covid-19 vaccine hub

accreditation
0:00
play article
Subscribers can listen to this article
France's President Emmanuel Macron and Cyril Ramaphosa, photographed in Paris in May.
France's President Emmanuel Macron and Cyril Ramaphosa, photographed in Paris in May.
Ludovic Marin/AFP
  • South Africa will get a new hub to manufacture Covid-19 messenger RNA vaccines. 
  • President Cyril Ramaphosa said the hub will also benefit the rest of the continent. 
  • French President Emmanuel Macron has pledged his support for this hub and future initiatives.

South Africa is set to get a new hub to manufacture vaccines, President Cyril Ramaphosa has announced.

He said, although it was historic and a step in the right direction, it would not stop South Africa from campaigning for the waiver of the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to enable poorer countries to manufacture their own vaccines. 

Ramaphosa addressed a joint press conference with French President Emmanuel Macron on Monday evening, facilitated by the World Health Organisation (WHO). 

Macron, who called Ramaphosa "my friend", said this partnership was the result of his state visit to South Africa at the end of last month. 

READ | Ramaphosa accuses Big Pharma of 'selfish, unjust' vaccine policy

South Africa's Biovac Institute, which has a partnership with France, has partnered with Afrigen Biologics and Vaccines, a network of universities, and the Africa Centres for Disease Control and Prevention to establish Africa's first Covid messenger RNA vaccine technology transfer hub. 

The World Health Organisation on 16 April issued a call for Expression of Interest to establish such hubs to scale-up production and access to Covid-19 vaccines, WHO Director-General Tedros Adhanom Ghebreyesus said.

Ramaphosa said the hub was the start of a process, and the laying of a foundation for health security for the world's most vulnerable. 

"We would like the negotiations taking place [on the TRIPS waiver] to proceed with speed," Ramaphosa said.

He said:

People in Africa are facing a rising wave of infections. In South Africa we are facing a third wave which seems to be more severe than the first and the second one and the only defence that we have is that we have vaccines.

Other WHO officials at the briefing, however, pointed out that social prevention measures, such as mask-wearing, the washing of hands and avoiding closed spaces and crowds were still among the most effective for bringing down infections. 

Ramaphosa said the new initiative shouldn't just be seen as benefiting South Africa, but the entire African continent. 

He said:

The Covid-19 pandemic has revealed the full extent of the vaccine gap between developed and developing economies, and how that gap can severely undermine global health security.

"This landmark initiative is a major advance in the international effort to build vaccine development and manufacturing capacity that will put Africa on a path to self determination," Ramaphosa continued.

"South Africa welcomes the opportunity to host a vaccine technology transfer hub and to build on the capacity and expertise that already exists on the continent to contribute to this effort."

Macron said it was a, "... great day for Africa" and for, "... all those who work towards a more equitable access to health products.

"I am proud for Biovac and our South African partners to have been selected by WHO, as France has been supporting them for years."

He said France would keep supporting future initiatives.

READ | Covid-19: SA in line to benefit as US lays out plan to share 55 million vaccine doses globally

WHO officials could not give a timeline for how long it would take for the first vaccines to be manufactured as a result of the hub, but estimated that it could take at least about nine to 12 months.

Technology transfer hubs are training facilities where the technology is established at industrial scale and clinical development performed, according to a WHO press release.

"Interested manufacturers from low- and middle-income countries can receive training and any necessary licenses to the technology. WHO and partners will bring in the production know-how, quality control and necessary licenses to a single entity to facilitate a broad and rapid technology transfer to multiple recipients," the release states. 

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, I believed it was authentic
7% - 276 votes
Yes, I didn't want to spend that much money on the original item
19% - 784 votes
No, I always shop at reputable stores
14% - 550 votes
No, I don't wear designer clothing
60% - 2442 votes
Vote
Rand - Dollar
14.92
+0.3%
Rand - Pound
20.40
+0.2%
Rand - Euro
17.49
+0.2%
Rand - Aus dollar
10.87
-0.2%
Rand - Yen
0.13
+0.1%
Gold
1,759.53
+0.5%
Silver
22.65
+1.0%
Palladium
1,989.50
+0.8%
Platinum
1,000.50
+1.4%
Brent Crude
78.09
+1.1%
Top 40
57,643
0.0%
All Share
64,049
0.0%
Resource 10
57,254
0.0%
Industrial 25
82,879
0.0%
Financial 15
14,316
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE